Biopharmaceutical R&D developer of next-generation cannabinoid medicines (CBD, THC) for patients to improve health outcomes and quality of life. Medicines produced to GMP and ISO standards using environmentally friendly, solvent-free methods to deliver pure, high-quality therapeutic cannabinoid compounds.